Non-Alcoholic Fatty Liver Disease (NAFLD) is now the most prevalent form of chronic liver
disease, affecting 10%–20% of the general paediatric population. Within the next 10 years it …

The gut microbiota plays critical roles in development of obese-related metabolic diseases
such as nonalcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), and insulin …

Introduction To evaluate the efficacy of empagliflozin compared to pioglitazone in patients
with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM). Methods In this …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …

Non-alcoholic fatty liver disease (NAFLD) has an increasing prevalence in Western society.
Unfortunately, the pathogenesis of NAFLD, from hepatic lipid overload, steatosis to non …

Steatotic liver grafts represent the most common type of “extended criteria” organs that have
been introduced during the last two decades due to the disparity between liver transplant …

To test the hypothesis that metformin protects against fructose-induced steatosis, and if so, to
elucidate underlying mechanisms, C57BL/6J mice were either fed 30% fructose solution or …

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease mainly caused by high-fat diets and sudden feed changes, vitamin and energy …

ETHNOPHARMACOLOGICAL RELEVANCE: The seed of Entada phaseoloides (L.)
Merr.(Entada phaseoloides) has been long used as an effective herb for the treatment of …

The incidence of nonalcoholic fatty liver disease (NAFLD) is growing worldwide.
Epidemiological data suggest a strong relationship between NAFLD and T2DM. This is …